Global Peptide Therapeutics Market Professional Survey Report 2017

Publisher Name :
Date: 12-Sep-2017
No. of pages: 107
Inquire Before Buying

This report studies Peptide Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Pfizer

- Eli Lilly and Company

- Bachem Holding

- Amgen

- Roche

- GlaxoSmithKline

- Novartis

- Sanofi

- Takeda Pharmaceutical Company

- Teva Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- by Phase

- - Liquid Phase

- - Solid Phase

- - Hybrid Phase

- by Type of Molecule

- - Vasopressin

- - Somatostatin

- - Calcitonin

- - Immunopeptide

- - Natriuretic

- - Others

By Application, the market can be split into

- Hospitals Pharmacies

- Retail Pharmacies

- Drug Stores

- E-Commerce

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Peptide Therapeutics Market Professional Survey Report 2017

Table of Contents
Global Peptide Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Peptide Therapeutics
1.1 Definition and Specifications of Peptide Therapeutics
1.1.1 Definition of Peptide Therapeutics
1.1.2 Specifications of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
1.2.1 Liquid Phase
1.2.2 Solid Phase
1.2.3 Hybrid Phase
1.3 Applications of Peptide Therapeutics
1.3.1 Hospitals Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Peptide Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peptide Therapeutics
2.3 Manufacturing Process Analysis of Peptide Therapeutics
2.4 Industry Chain Structure of Peptide Therapeutics
3 Technical Data and Manufacturing Plants Analysis of Peptide Therapeutics
3.1 Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2016
4 Global Peptide Therapeutics Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Peptide Therapeutics Capacity and Growth Rate Analysis
4.2.2 2016 Peptide Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Peptide Therapeutics Sales and Growth Rate Analysis
4.3.2 2016 Peptide Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Peptide Therapeutics Sales Price
4.4.2 2016 Peptide Therapeutics Sales Price Analysis (Company Segment)
5 Peptide Therapeutics Regional Market Analysis
5.1 North America Peptide Therapeutics Market Analysis
5.1.1 North America Peptide Therapeutics Market Overview
5.1.2 North America 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Peptide Therapeutics Sales Price Analysis
5.1.4 North America 2016 Peptide Therapeutics Market Share Analysis
5.2 China Peptide Therapeutics Market Analysis
5.2.1 China Peptide Therapeutics Market Overview
5.2.2 China 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Peptide Therapeutics Sales Price Analysis
5.2.4 China 2016 Peptide Therapeutics Market Share Analysis
5.3 Europe Peptide Therapeutics Market Analysis
5.3.1 Europe Peptide Therapeutics Market Overview
5.3.2 Europe 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Peptide Therapeutics Sales Price Analysis
5.3.4 Europe 2016 Peptide Therapeutics Market Share Analysis
5.4 Southeast Asia Peptide Therapeutics Market Analysis
5.4.1 Southeast Asia Peptide Therapeutics Market Overview
5.4.2 Southeast Asia 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Peptide Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2016 Peptide Therapeutics Market Share Analysis
5.5 Japan Peptide Therapeutics Market Analysis
5.5.1 Japan Peptide Therapeutics Market Overview
5.5.2 Japan 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Peptide Therapeutics Sales Price Analysis
5.5.4 Japan 2016 Peptide Therapeutics Market Share Analysis
5.6 India Peptide Therapeutics Market Analysis
5.6.1 India Peptide Therapeutics Market Overview
5.6.2 India 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Peptide Therapeutics Sales Price Analysis
5.6.4 India 2016 Peptide Therapeutics Market Share Analysis
6 Global 2012-2017E Peptide Therapeutics Segment Market Analysis (by Type)
6.1 Global 2012-2017E Peptide Therapeutics Sales by Type
6.2 Different Types of Peptide Therapeutics Product Interview Price Analysis
6.3 Different Types of Peptide Therapeutics Product Driving Factors Analysis
6.3.1 by Phase of Peptide Therapeutics Growth Driving Factor Analysis
6.3.2 by Type of Molecule of Peptide Therapeutics Growth Driving Factor Analysis
7 Global 2012-2017E Peptide Therapeutics Segment Market Analysis (by Application)
7.1 Global 2012-2017E Peptide Therapeutics Consumption by Application
7.2 Different Application of Peptide Therapeutics Product Interview Price Analysis
7.3 Different Application of Peptide Therapeutics Product Driving Factors Analysis
7.3.1 Hospitals Pharmacies of Peptide Therapeutics Growth Driving Factor Analysis
7.3.2 Retail Pharmacies of Peptide Therapeutics Growth Driving Factor Analysis
7.3.3 Drug Stores of Peptide Therapeutics Growth Driving Factor Analysis
7.3.4 E-Commerce of Peptide Therapeutics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Peptide Therapeutics
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Pfizer 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2016 Peptide Therapeutics Business Region Distribution Analysis
8.2 Eli Lilly and Company
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eli Lilly and Company 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eli Lilly and Company 2016 Peptide Therapeutics Business Region Distribution Analysis
8.3 Bachem Holding
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Bachem Holding 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Bachem Holding 2016 Peptide Therapeutics Business Region Distribution Analysis
8.4 Amgen
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Amgen 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Amgen 2016 Peptide Therapeutics Business Region Distribution Analysis
8.5 Roche
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Roche 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Roche 2016 Peptide Therapeutics Business Region Distribution Analysis
8.6 GlaxoSmithKline
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 GlaxoSmithKline 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 GlaxoSmithKline 2016 Peptide Therapeutics Business Region Distribution Analysis
8.7 Novartis
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novartis 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novartis 2016 Peptide Therapeutics Business Region Distribution Analysis
8.8 Sanofi
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Sanofi 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Sanofi 2016 Peptide Therapeutics Business Region Distribution Analysis
8.9 Takeda Pharmaceutical Company
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Takeda Pharmaceutical Company 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Takeda Pharmaceutical Company 2016 Peptide Therapeutics Business Region Distribution Analysis
8.10 Teva Pharmaceutical
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Teva Pharmaceutical 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Teva Pharmaceutical 2016 Peptide Therapeutics Business Region Distribution Analysis
9 Development Trend of Analysis of Peptide Therapeutics Market
9.1 Global Peptide Therapeutics Market Trend Analysis
9.1.1 Global 2017-2022 Peptide Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Peptide Therapeutics Sales Price Forecast
9.2 Peptide Therapeutics Regional Market Trend
9.2.1 North America 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.2 China 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.3 Europe 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.5 Japan 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.6 India 2017-2022 Peptide Therapeutics Consumption Forecast
9.3 Peptide Therapeutics Market Trend (Product Type)
9.4 Peptide Therapeutics Market Trend (Application)
10 Peptide Therapeutics Marketing Type Analysis
10.1 Peptide Therapeutics Regional Marketing Type Analysis
10.2 Peptide Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Peptide Therapeutics by Region
10.4 Peptide Therapeutics Supply Chain Analysis
11 Consumers Analysis of Peptide Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Peptide Therapeutics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Peptide Therapeutics
Table Product Specifications of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure Global Production Market Share of Peptide Therapeutics by Type in 2016
Figure Liquid Phase Picture
Table Major Manufacturers of Liquid Phase
Figure Solid Phase Picture
Table Major Manufacturers of Solid Phase
Figure Hybrid Phase Picture
Table Major Manufacturers of Hybrid Phase
Table Applications of Peptide Therapeutics
Figure Global Consumption Volume Market Share of Peptide Therapeutics by Application in 2016
Figure Hospitals Pharmacies Examples
Table Major Consumers in Hospitals Pharmacies
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Drug Stores Examples
Table Major Consumers in Drug Stores
Figure E-Commerce Examples
Table Major Consumers in E-Commerce
Figure Market Share of Peptide Therapeutics by Regions
Figure North America Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure China Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure India Peptide Therapeutics Market Size (Million USD) (2012-2022)
Table Peptide Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peptide Therapeutics in 2016
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Industry Chain Structure of Peptide Therapeutics
Table Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Peptide Therapeutics 2012-2017
Figure Global 2012-2017E Peptide Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Peptide Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Peptide Therapeutics Capacity and Growth Rate
Table 2016 Global Peptide Therapeutics Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Peptide Therapeutics Sales (K Units) and Growth Rate
Table 2016 Global Peptide Therapeutics Sales (K Units) List (Company Segment)
Table 2012-2017E Global Peptide Therapeutics Sales Price (USD/Unit)
Table 2016 Global Peptide Therapeutics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure North America 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure North America 2016 Peptide Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure China 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure China 2016 Peptide Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Europe 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Europe 2016 Peptide Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Southeast Asia 2016 Peptide Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Japan 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Japan 2016 Peptide Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure India 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure India 2016 Peptide Therapeutics Sales Market Share
Table Global 2012-2017E Peptide Therapeutics Sales (K Units) by Type
Table Different Types Peptide Therapeutics Product Interview Price
Table Global 2012-2017E Peptide Therapeutics Sales (K Units) by Application
Table Different Application Peptide Therapeutics Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Peptide Therapeutics Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly and Company Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly and Company Peptide Therapeutics Business Region Distribution
Table Bachem Holding Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bachem Holding Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bachem Holding Peptide Therapeutics Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Peptide Therapeutics Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Peptide Therapeutics Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Peptide Therapeutics Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Peptide Therapeutics Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Peptide Therapeutics Business Region Distribution
Table Takeda Pharmaceutical Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Pharmaceutical Company Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Takeda Pharmaceutical Company Peptide Therapeutics Business Region Distribution
Table Teva Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Peptide Therapeutics Business Region Distribution
Figure Global 2017-2022 Peptide Therapeutics Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Peptide Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Peptide Therapeutics Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Peptide Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Units) of Peptide Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Peptide Therapeutics by Region
  • Liver Fibrosis - Pipeline Review, H2 2017
    Published: 19-Sep-2017        Price: US 2000 Onwards        Pages: 216
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Fibrosis - Pipeline Review, H2 2017, provides an overview of the Liver Fibrosis (Gastrointestinal) pipeline landscape.Liver fibrosis is a scarring process which results in inflammation and liver cell death. Symptoms include abdominal pain, easy bruising, lack of appetite, nausea, tenderness and enlargement of the liver, weight loss and yellowing of skin and eyes. Risk factors include age, heavy alcohol c......
  • Pancreatitis - Pipeline Review, H2 2017
    Published: 19-Sep-2017        Price: US 2000 Onwards        Pages: 74
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Pipeline Review, H2 2017, provides an overview of the Pancreatitis (Gastrointestinal) pipeline landscape.Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdo......
  • Acromegaly - Pipeline Review, H2 2017
    Published: 19-Sep-2017        Price: US 2000 Onwards        Pages: 80
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H2 2017, provides an overview of the Acromegaly (Hormonal Disorders) pipeline landscape.Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth and sleep apnea. Treatment inc......
  • Liver Transplant Rejection - Pipeline Review, H2 2017
    Published: 19-Sep-2017        Price: US 2000 Onwards        Pages: 67
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection - Pipeline Review, H2 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape.Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability to regenerate or grow, unlike any other organ in the body. Liver transplant replaces an injured or diseased liver with a healthy one. An entire liver or just a ......
  • Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 32
    Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2017, provides an overview of the Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline landscape. Pseudomonas aeruginosa has become an important cause of pneumonia. It is the most common pathogen isolated from patients who have been hospita......
  • Achondroplasia - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 36
    Achondroplasia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Pipeline Review, H2 2017, provides an overview of the Achondroplasia (Musculoskeletal Disorders) pipeline landscape. Achondroplasia is a bone growth disorder that causes disproportionate dwarfism. This is caused by mutations in the FGFR3 gene. Symptoms include decreased muscle tone, apnea, hydrocephalus, ......
  • Dupuytren Contracture - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 31
    Dupuytren Contracture - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dupuytren Contracture - Pipeline Review, H2 2017, provides an overview of the Dupuytren Contracture (Musculoskeletal Disorders) pipeline landscape. Dupuytren contracture is a hand deformity that usually develops slowly, over decades. Dupuytren contracture affects the connective tissue under the skin of the palm. It......
  • Fibrosis - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 122
    Fibrosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosis - Pipeline Review, H2 2017, provides an overview of the Fibrosis (Musculoskeletal Disorders) pipeline landscape. Fibrosis is the excessive formation of fibrous bands of scar tissue in between muscle fibers. Fibrous scar tissue develops after the muscle has been damaged to fill in the open spaces in the injured muscle, ......
  • Anesthetic Effect - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 88
    Anesthetic Effect - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anesthetic Effect - Pipeline Review, H2 2017, provides an overview of the Anesthetic Effect (Central Nervous System) pipeline landscape. Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs